D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 27,426 408 World Ranking 12704 National Ranking 1168

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

The scientist’s investigation covers issues in Internal medicine, Fatty liver, Gastroenterology, Pathology and Fibrosis. He has included themes like Endocrinology and Surgery in his Internal medicine study. His Fatty liver research integrates issues from Steatosis, Surgical oncology, Liver injury and Chemotherapy.

His research in Gastroenterology intersects with topics in Severity of illness, Metabolic syndrome and Hepatitis. His work carried out in the field of Pathology brings together such families of science as Epithelial–mesenchymal transition and Alcoholic liver disease. Alastair D. Burt interconnects Chronic liver disease and Cirrhosis in the investigation of issues within Fibrosis.

His most cited work include:

  • The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD (1634 citations)
  • Serum markers detect the presence of liver fibrosis: A cohort study (824 citations)
  • The natural history of nonalcoholic fatty liver: A follow-up study (806 citations)

What are the main themes of his work throughout his whole career to date?

Alastair D. Burt spends much of his time researching Internal medicine, Pathology, Gastroenterology, Fatty liver and Fibrosis. His work on Liver biopsy, Biopsy and Cirrhosis as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines. His study in Liver biopsy is interdisciplinary in nature, drawing from both Liver transplantation and Surgery.

His Pathology research is multidisciplinary, incorporating elements of Hepatocellular carcinoma, Liver injury and Alcoholic liver disease. His Gastroenterology study frequently draws connections to other fields, such as Nonalcoholic fatty liver disease. Much of his study explores Fatty liver relationship to Steatosis.

He most often published in these fields:

  • Internal medicine (43.69%)
  • Pathology (37.15%)
  • Gastroenterology (25.00%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (43.69%)
  • Fatty liver (17.06%)
  • Pathology (37.15%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Fatty liver, Pathology, Gastroenterology and Steatohepatitis. His work on Fibrosis, Colonoscopy and Biopsy as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His work focuses on many connections between Fatty liver and other disciplines, such as Steatosis, that overlap with his field of interest in Mitochondrion, Hepatocyte and Proinflammatory cytokine.

His research on Pathology focuses in particular on Histopathology. His Gastroenterology study combines topics in areas such as Body mass index, Randomized controlled trial, Non invasive, Nonalcoholic fatty liver disease and Non alcoholic. His research on Steatohepatitis also deals with topics like

  • Cirrhosis which connect with TM6SF2 and Bioinformatics,
  • Liver biopsy which connect with Severity of illness.

Between 2014 and 2021, his most popular works were:

  • Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management (514 citations)
  • Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management (514 citations)
  • Cellular senescence drives age-dependent hepatic steatosis. (298 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

His primary areas of investigation include Fatty liver, Internal medicine, Gastroenterology, Steatosis and Pathology. Alastair D. Burt mostly deals with Steatohepatitis in his studies of Fatty liver. In general Internal medicine study, his work on Fibrosis, Colorectal cancer, Colonoscopy and Randomized controlled trial often relates to the realm of Aspartate Aminotransferases, thereby connecting several areas of interest.

His Gastroenterology research includes elements of Liver pathology, Predictive value of tests, Non invasive and Hyperplastic Polyp. As a part of the same scientific family, Alastair D. Burt mostly works in the field of Steatosis, focusing on Cirrhosis and, on occasion, Liver biopsy and Nonalcoholic fatty liver disease. His work on Biopsy and Carcinoma as part of general Pathology research is frequently linked to Sign out and Columnar Metaplasia, bridging the gap between disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi.
Hepatology (2007)

2730 Citations

Serum markers detect the presence of liver fibrosis: A cohort study

William M.C. Rosenberg;Michael Voelker;Robert Thiel;Michael Becka.
Gastroenterology (2004)

1302 Citations

The natural history of nonalcoholic fatty liver: A follow-up study

Mohd R. Teli;Oliver F. W. James;Alastair D. Burt;Mark K. Bennett.
Hepatology (1995)

1203 Citations

Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia

Masamichi Kojiro;Ian R. Wanless;Venancio Alves;Sunil Badve.
Hepatology (2009)

951 Citations

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

Stuart McPherson;Stuart McPherson;Tim Hardy;Elsbeth Henderson;Alastair D. Burt;Alastair D. Burt.
Journal of Hepatology (2015)

950 Citations

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Indra Neil Guha;Julie Parkes;Paul Roderick;Dipanker Chattopadhyay.
Hepatology (2007)

816 Citations

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

Stuart McPherson;Stephen F Stewart;Elsbeth Henderson;Alastair D Burt.
Gut (2010)

769 Citations

EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease

Philippe Mathurin;Antoine Hadengue;Giovanni Addolorato;Alastair Burt.
Journal of Hepatology (2012)

694 Citations

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

M.R Teli;C.P Day;O.F.W James;A.D Burt.
The Lancet (1995)

585 Citations

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

Yang-Lin Liu;Helen L Reeves;Alastair D Burt;Dina Tiniakos.
Nature Communications (2014)

531 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alastair D. Burt

Quentin M. Anstee

Quentin M. Anstee

Newcastle University

Publications: 132

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 124

Christopher P. Day

Christopher P. Day

Newcastle University

Publications: 85

Luca Valenti

Luca Valenti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 84

Rohit Loomba

Rohit Loomba

University of California, San Diego

Publications: 75

Leon A. Adams

Leon A. Adams

University of Western Australia

Publications: 72

David Jones

David Jones

Newcastle University

Publications: 67

Scott L. Friedman

Scott L. Friedman

Icahn School of Medicine at Mount Sinai

Publications: 63

Christopher D. Byrne

Christopher D. Byrne

National Institute for Health Research

Publications: 62

Elisabetta Bugianesi

Elisabetta Bugianesi

University of Turin

Publications: 61

Keith D. Lindor

Keith D. Lindor

Arizona State University

Publications: 61

Stefano Romeo

Stefano Romeo

University of Gothenburg

Publications: 59

Jacob George

Jacob George

University of Sydney

Publications: 59

Massimo Pinzani

Massimo Pinzani

The Royal Free Hospital

Publications: 58

Anna Mae Diehl

Anna Mae Diehl

Duke University

Publications: 57

Arun J. Sanyal

Arun J. Sanyal

Virginia Commonwealth University

Publications: 56

Trending Scientists

Boris Dubrovin

Boris Dubrovin

International School for Advanced Studies

Alex Aben-Athar Kipman

Alex Aben-Athar Kipman

Microsoft (United States)

Mark J. Schulz

Mark J. Schulz

University of Cincinnati

Jürgen Brugger

Jürgen Brugger

École Polytechnique Fédérale de Lausanne

Minoru Fujii

Minoru Fujii

Kobe University

Linda M. Brzustowicz

Linda M. Brzustowicz

Rutgers, The State University of New Jersey

Bernard L. Trumpower

Bernard L. Trumpower

Dartmouth College

Andrew J.H. Smith

Andrew J.H. Smith

University of Edinburgh

Wen-Sheng Shu

Wen-Sheng Shu

South China Normal University

Egill Hauksson

Egill Hauksson

California Institute of Technology

Peter D. Ward

Peter D. Ward

University of Washington

Mario Giampietro

Mario Giampietro

Autonomous University of Barcelona

Krzysztof Krawczynski

Krzysztof Krawczynski

Centers for Disease Control and Prevention

Paul L. Hewitt

Paul L. Hewitt

University of British Columbia

Robert C. Green

Robert C. Green

Brigham and Women's Hospital

Michitoshi Yoshida

Michitoshi Yoshida

National Astronomical Observatory of Japan

Something went wrong. Please try again later.